![May Kin Ho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
May Kin Ho
Directeur/Membre du Conseil chez
PAREXEL INTERNATIONAL CORPORATION
Fortune : 3 M $ au 31/05/2026
Profil
May Kin Ho is currently Director at PAREXEL International Corp.
since 2018, Independent Director at BioMarin Pharmaceutical, Inc. since 2021, Independent Director at Agios Pharmaceuticals, Inc. since 2015, Independent Director at Kyntra Bio, Inc. since 2018, Director at The Aaron Diamond AIDS Research Center since 2005, Director at Pelage Pharmaceuticals, Inc., Director at Parexel International Corp.
Ltd. since 2018, Director at Institute For Protein Innovation, Inc. since 2016, Independent Director at Neumora Therapeutics, Inc. since 2021, Venture Partner at Qiming Venture Partners Ltd., and Managing Partner at Viridian Global Logistics, Inc. Former roles include Independent Director at PAREXEL International Corp.
from 2015 to 2017, Independent Director at GRAIL, Inc. from 2019 to 2021, Director-Strategic Planning, Marketing & Research at DuPont Merck Pharmaceutical Co., Director-Strategic Planning, Marketing & Research at Dupont De Nemours & Co., Inc., Partner & Co-Head-Healthcare at The Goldman Sachs Group, Inc. from 2010 to 2015, and Research Analyst at Goldman Sachs & Co. LLC from 1992 to 2013.
Education includes a doctorate conferred in 1980 and an undergraduate degree conferred in 1975, both from State University of New York at Downstate Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/06/2026 | 35 500 ( 0,02 % ) | 2 M $ | 31/05/2026 | |
| 18/06/2026 | 19 848 ( 0,03 % ) | 583 531 $ | 31/05/2026 | |
KYNTRA BIO, INC. 0,23 % | 12/06/2026 | 9 286 ( 0,23 % ) | 64 073 $ | 31/05/2026 |
| 27/05/2026 | 20 100 ( 0,01 % ) | 37 185 $ | 31/05/2026 |
Postes actifs de May Kin Ho
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/06/2015 |
| KYNTRA BIO, INC. | Directeur/Membre du Conseil | 06/12/2018 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 17/02/2021 |
| NEUMORA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| PAREXEL INTERNATIONAL CORPORATION | Directeur/Membre du Conseil | 01/03/2018 |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners invests in companies located in China. The firm targets companies operating in the fields of technology, consumer and healthcare sectors. It provides financing for growth and early stage capital requirements. | Private Equity Investor | - |
Parexel International Corp. Ltd.
 Parexel International Corp. Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 12/03/2018 |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science research and accelerate the development of modern medicines | Directeur/Membre du Conseil | 01/01/2016 |
The Aaron Diamond AIDS Research Center
 The Aaron Diamond AIDS Research Center Miscellaneous Commercial ServicesCommercial Services Provides research & clinical testing solutions for HIV and AIDS | Directeur/Membre du Conseil | 01/01/2005 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de May Kin Ho
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
| ░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Formation de May Kin Ho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners invests in companies located in China. The firm targets companies operating in the fields of technology, consumer and healthcare sectors. It provides financing for growth and early stage capital requirements. | Finance |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Aaron Diamond AIDS Research Center
The Aaron Diamond AIDS Research Center Miscellaneous Commercial ServicesCommercial Services Provides research & clinical testing solutions for HIV and AIDS | Commercial Services |
Dupont De Nemours & Co., Inc.
 Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Manufactures hybrid corn and soybean seeds | Process Industries |
Viridian Global Logistics, Inc. | |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Parexel International Corp. Ltd.
Parexel International Corp. Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Institute For Protein Innovation, Inc.
Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science research and accelerate the development of modern medicines | Commercial Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Pelage Pharmaceuticals, Inc.
 Pelage Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops hair loss treatment products | Health Technology |
Choisissez Zonebourse 
